Buerger's Disease
- Thromboangiitis obliterans (Buerger's disease) is a NON-ATHEROSCLEROTIC, SEGMENTAL, INFLAMMATORY occlusive disease of the SMALL and MEDIUM arteries and VEINS of the extremities; the occluding thrombus is highly cellular and inflammatory and characteristically spares the underlying vessel-wall architecture, distinguishing it from atherosclerosis and from a true necrotising vasculitis.
- It is strongly TRIGGERED by TOBACCO and occurs almost exclusively in SMOKERS, typically YOUNG adults (classically men, though increasingly women) with onset before about 45-50 years of age; substantial tobacco exposure is essential to the disease and its activity.
- It presents with DISTAL ischaemia - foot/instep or forearm/hand claudication, rest pain, and DIGITAL ULCERATION and GANGRENE of the fingers and toes - together with MIGRATORY SUPERFICIAL THROMBOPHLEBITIS and RAYNAUD'S phenomenon; the disease is distal and segmental, so proximal pulses are usually preserved while the digital vessels are occluded.
- DIAGNOSIS is essentially clinical and one of EXCLUSION: a young smoker with distal ischaemia, an absence of the usual atherosclerotic risk factors and embolic sources, normal proximal arteries, and CORKSCREW (tortuous 'tree-root') COLLATERALS around segmental occlusions on angiography; one must exclude atherosclerosis, diabetes, an embolic source (echo), autoimmune/connective-tissue disease (autoantibodies) and hypercoagulable states.
- The ONLY treatment that genuinely changes the course of the disease is COMPLETE and PERMANENT cessation of ALL tobacco - continued smoking drives progression and amputation, whereas stopping arrests the disease and is associated with markedly lower amputation rates; this message must be delivered unambiguously and supported actively.
- REVASCULARISATION is of LIMITED value because the disease is distal and segmental with poor distal targets; surgical or endovascular revascularisation (including palmar-arch angioplasty in the hand) is reserved for selected cases with critical ischaemia and suitable anatomy and is a SUPPORTIVE limb-salvage measure rather than a cure - according to PubMed, even with revascularisation MINOR amputations remain frequent, although major amputation can often be avoided; wound care, analgesia, and where appropriate vasodilators/prostanoids (e.g. iloprost) and sympathectomy are adjuncts.
- “Buerger's = young SMOKER + DISTAL ischaemia/digital gangrene + migratory superficial thrombophlebitis + Raynaud's. Non-atherosclerotic, segmental, small/medium arteries AND veins; thrombus spares the vessel wall.
- “Diagnosis = exclusion + CORKSCREW collaterals on angiography; normal proximal arteries; exclude emboli/atheroma/diabetes/autoimmune/hypercoagulable.
- “ONLY disease-modifying treatment = total smoking cessation. Revascularisation limited (distal disease, poor targets) - supportive limb salvage; minor amputations common, major usually avoidable if they stop smoking.
Young smoker with distal ischaemia, digital ulcers/gangrene, migratory superficial thrombophlebitis and Raynaud's - non-atherosclerotic, small/medium arteries and veins, normal proximal arteries, corkscrew collaterals on angiography.
Complete, permanent smoking cessation is the only treatment that changes the disease. Revascularisation is limited (distal, poor targets). Continued smoking = progression and amputation.
Pathology & Presentation
Buerger's disease is a non-atherosclerotic, segmental, inflammatory occlusive disease of the small and medium arteries and veins of the extremities. The occluding thrombus is highly cellular and inflammatory and characteristically spares the vessel-wall architecture, which distinguishes it from atherosclerosis and from a destructive necrotising vasculitis. It occurs almost exclusively in smokers, typically young adults with onset before about 45-50. It presents with distal ischaemia - instep/forearm claudication, rest pain, digital ulceration and gangrene - and with migratory superficial thrombophlebitis and Raynaud's phenomenon. Because it is distal and segmental, proximal pulses are usually preserved while the digital arteries are occluded.
Diagnosis - A Clinical Diagnosis of Exclusion
There is no single confirmatory test; the diagnosis is clinical and one of exclusion:
- Typical patient/picture: young smoker, distal ischaemia, digital ulcers/gangrene, thrombophlebitis, Raynaud's; onset before ~45-50.
- Angiography: segmental occlusions of distal vessels with corkscrew (tortuous 'tree-root') collaterals and normal proximal arteries (no atheroma).
- Exclude: atherosclerosis and its risk factors, diabetes, an embolic source (echocardiography, proximal aneurysm), autoimmune/connective-tissue disease (autoantibodies, inflammatory markers) and hypercoagulable states.
- Allen's test is often abnormal (involvement of both forearm arteries / palmar arch).
Management
- Complete, permanent smoking cessation - the only disease-modifying treatment; deliver the message unambiguously and support it actively (counselling, pharmacotherapy). Continued tobacco drives progression and amputation; stopping arrests the disease and lowers amputation rates.
- Wound and limb care: meticulous foot/hand care, treat infection, analgesia for ischaemic rest pain.
- Pharmacological adjuncts: vasodilators and prostanoids (e.g. iloprost) may help ischaemic rest pain and ulcer healing; address pain (including for ulcers/gangrene).
- Revascularisation - limited: the distal, segmental pattern gives poor distal targets, so surgical or endovascular revascularisation (including palmar-arch angioplasty in the hand) is reserved for selected critical ischaemia with suitable anatomy and is a supportive limb-salvage measure, not a cure - minor amputations remain frequent even after revascularisation, but major amputation can often be avoided.
- Sympathectomy and other adjuncts have a limited, selective role.
- Amputation: the most distal level that will heal, for established gangrene/intractable pain - far more likely if the patient continues to smoke.
The defining clinical truth of Buerger's disease is that it is a tobacco-driven disease and that complete, permanent cessation of all tobacco is the only intervention that changes its natural history. Revascularisation, prostanoids, sympathectomy and wound care are supportive and, because the disease is distal and segmental with poor targets, revascularisation often fails or only delays tissue loss - minor amputations are common even in revascularised limbs. A patient who continues to smoke will progress to further ulceration, gangrene and amputation regardless of any procedure, whereas one who stops can arrest the disease and frequently avoid major amputation. Therefore the central, non-negotiable management step - to be delivered clearly and supported actively - is total smoking cessation, and no operative plan should be framed as a substitute for it.
Evidence & Key Studies
Buerger disease (thromboangiitis obliterans) - clinical features, diagnosis and management
- Buerger disease is a non-atherosclerotic vasculitis triggered by substantial exposure to tobacco, usually affecting the small and medium arteries of the upper and lower extremities.
- The review sets out the clinical presentation, diagnostic criteria and work-up (non-invasive arterial studies and angiography, with typical distal findings).
- Management centres on smoking cessation, with revascularisation - surgical and endovascular - having a limited, selective role.
Endovascular revascularisation of upper-limb thromboangiitis obliterans via palmar-arch angioplasty
- In nine men with angiographically confirmed upper-extremity TAO (all active smokers), the radial artery was involved in all and the ulnar in most, with digital gangrene or ischaemic ulceration at presentation.
- Palmar-arch angioplasty was technically successful in 4 of 6 attempts; minor amputations occurred in 88.9% but no major amputations were required, and successful revascularisation improved wound healing and limb salvage.
- Endovascular revascularisation is a feasible supportive limb-salvage measure in selected patients rather than a definitive solution - outcomes remain variable and minor amputations are still frequent.
According to PubMed, the nature of Buerger's disease (a non-atherosclerotic, tobacco-triggered vasculitis of the small/medium arteries of the extremities), its diagnostic work-up, and the central role of smoking cessation with a limited role for revascularisation come from the cited Del Conde review; the limits of revascularisation in the upper limb (frequent minor amputations, major amputation often avoidable) from the cited Varim series. The classic clinical picture (young smoker, distal ischaemia, migratory thrombophlebitis, Raynaud's, corkscrew collaterals) is standard, well-established teaching. (See also our Raynaud's Phenomenon, Hypothenar Hammer Syndrome / Digital Artery Aneurysm and Hand Ischaemia topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A 38-year-old man who smokes presents with painful ulceration and early gangrene of two fingertips and a tender cord on his forearm. What is your diagnosis and management?”
Mnemonics & Memory Aids
BUERGER
Hook:BUERGER: Blokes who smoke, Ulcers/gangrene, Extremity small vessels, Raynaud's/phlebitis, Gangrene if they keep smoking, Exclusion + corkscrew collaterals, Renounce tobacco.
What it is
- Non-atherosclerotic, segmental, inflammatory occlusion of small/medium arteries AND veins
- Inflammatory thrombus that spares the vessel-wall architecture
- Strongly tobacco-driven; young adults (classically male)
Presentation
- Distal ischaemia: instep/forearm claudication, rest pain, digital ulcers/gangrene
- Migratory superficial thrombophlebitis; Raynaud's phenomenon
- Proximal pulses usually preserved (distal/segmental disease)
Diagnosis
- Clinical diagnosis of exclusion; abnormal Allen's test common
- Angiography: corkscrew collaterals, normal proximal arteries (no atheroma)
- Exclude atheroma/diabetes/emboli/autoimmune/hypercoagulable
Management
- Complete permanent smoking cessation - the ONLY disease-modifying treatment
- Wound care, analgesia, prostanoids (iloprost) for rest pain/ulcers
- Revascularisation limited/supportive; minor amputations common; amputate distal-most level that heals